Why Picard Medical, Inc.’s (PMI) Stock Is Down 24.04%
As of Tuesday, April 28, Picard Medical, Inc.’s PMI share price has dipped by 24.04%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
Commentary & Analysis
Why Picard Medical, Inc.’s (PMI) Stock Is Down 26.86%
As of Tuesday, April 28, Picard Medical, Inc.’s PMI share price has dipped by 26.86%, which has investors questioning if this is right time to buy.Omar Beirat
Why Picard Medical, Inc.’s (PMI) Stock Is Down 6.43%
As of Monday, April 27, Picard Medical, Inc.’s PMI share price has dipped by 6.43%, which has investors questioning if this is right time to buy.Michael Rose
Why Picard Medical, Inc.’s (PMI) Stock Is Down 6.83%
As of Friday, April 10, Picard Medical, Inc.’s PMI share price has dipped by 6.83%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Picard Medical, Inc.’s (PMI) Stock Is Up 6.25%
As of Tuesday, April 07, Picard Medical, Inc.’s PMI share price has surged by 6.25%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | PMI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $16.8 | $437.4 | 10% |
|
| Shares Out (Mil) | 1.9 | 40.7 | 7% |
|
| Institutional Ownership | 69.7% | 83.6% | 43% |
|
| Float (Mil) | 1.3 | 35.5 | 4% |
|
| Beta | na | 0.85 | na |
|
| Avg Daily Volume (000s) | 89 | 333 | 35% |
|
| Price Change (52-week) |
(98.9%) | 68.1% | 2% |
|
| Growth | PMI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.7%) | na |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | 1 | |
| Current EPS | ($1.500) | ($8.500) | ($4.500) | |
| Month Ago EPS | ($1.500) | na | ($4.500) | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | ($1.500) | na | ($4.500) | |
| Year/Year Chg | (50.8%) | (77.2%) | na | |
| Financials | PMI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6 | $141 | 7% |
|
| Net Income (TTM) (Mil) | ($28) | ($9) | 21% |
|
| EPS (TTM) | ($17.884) | ($0.400) | 3% |
|
| Operating Cash Flow (TTM) (Mil) | ($16) | ($1) | 17% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $27 | 0% |
|
| Enterprise Value (Q1) (Mil) | $12 | $381 | 9% |
|
| Valuation | PMI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 8.66 | 2.62 | 90% |
|
| P/E | na | 30.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | PMI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 18.6% | 59.0% | 19% |
|
| Net Margin | (444.3%) | (6.6%) | 2% |
|
| ROA | (268.3%) | (11.3%) | 1% |
|
| ROE | 106.1% | (10.1%) | 97% |
|
| Liabilities to Assets | 81.3% | 47.1% | 76% |
|
| F-Score | 5 | 4 | 50% |
|
Picard Medical, Inc. did not pass any screens on 11/4/2026.
